The Effect of the Finger Feeding Method Premature Babies
Launched by ATATURK UNIVERSITY · Jan 11, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called finger feeding, where fathers help their premature babies learn to feed by using their fingers instead of a bottle. The goal is to see if this approach can help babies transition to oral feeding more quickly and improve their ability to suck. The trial will include premature babies born between 29 to 31 weeks, weighing at least 1300 grams, and who are stable in their health. Only fathers who are able to read, write, and speak Turkish and are willing to participate will be included.
If you and your baby qualify for this study, you can expect to be involved in a process where you help your baby feed using your finger, which may support their feeding skills. It's important to know that the study will not include babies who are not stable in their health or those whose fathers have certain health conditions. This trial is still in the planning stages and has not started recruiting participants yet.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Premature babies at 29-31 weeks
- • Birth weight of 1300 g or more
- • Those whose 1st and 5th minute Apgar scores are over 6
- • Those whose vital signs and health status are stable
- • In babies who have received mechanical ventilation and continuous positive air pressure support, those who have passed 48 hours after stability has been achieved
- • No facial or oral anomalies
- • Premature babies without swallowing difficulties
- • Those fed via nasogastric tube
- • Fathers who can read, write and speak Turkish
- • Fathers of preterm babies who agreed to participate in the research.
- Exclusion Criteria:
- • Those whose vital and health conditions are unstable
- • Those whose father has a skin condition or those who developed it later
- • Any upper respiratory tract infection in the father
- • Premature babies without swallowing difficulties
- • Fathers who cannot read, write or speak Turkish
- • Fathers with preterm babies who do not consent to this study will not be included in the scope of the research.
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erzurum, Center, Turkey
Patients applied
Trial Officials
HASAN KAHVECİ
Study Chair
zulbiye.demir@atauni.edu.tr
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported